Y-mAbs Therapeutics Inc - ESG Rating & Company Profile powered by AI
This article includes a questions and answers section for Y-mAbs Therapeutics Inc. Comprehensive Sustainability analysis of Y-mAbs Therapeutics Inc can be accessed by registering for free. Check the end of the page for potential risks for Y-mAbs Therapeutics Inc based on sector, location and size.
Y-mAbs Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.0, social score of 4.8 and governance score of 4.8.
3.9
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
1004 | Xeris Pharmaceuticals Inc | 4.0 | High |
1004 | Xenon Pharmaceuticals Inc | 4.0 | High |
... | ... | ... | |
1089 | Y-mAbs Therapeutics Inc | 3.9 | Medium |
1089 | Aclaris Therapeutics Inc | 3.9 | Medium |
1089 | Allogene Therapeutics Inc | 3.9 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Y-mAbs Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Y-mAbs Therapeutics Inc disclose current and historical energy intensity?
Does Y-mAbs Therapeutics Inc report the average age of the workforce?
Does Y-mAbs Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does Y-mAbs Therapeutics Inc disclose its ethnicity pay gap?
Does Y-mAbs Therapeutics Inc disclose cybersecurity risks?
Does Y-mAbs Therapeutics Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Y-mAbs Therapeutics Inc offer flexible work?
Does Y-mAbs Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Y-mAbs Therapeutics Inc disclose the number of employees in R&D functions?
Does Y-mAbs Therapeutics Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Y-mAbs Therapeutics Inc conduct supply chain audits?
Does Y-mAbs Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Y-mAbs Therapeutics Inc conduct 360 degree staff reviews?
Does Y-mAbs Therapeutics Inc disclose the individual responsible for D&I?
Does Y-mAbs Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Y-mAbs Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does Y-mAbs Therapeutics Inc disclose water use targets?
Does Y-mAbs Therapeutics Inc have careers partnerships with academic institutions?
Did Y-mAbs Therapeutics Inc have a product recall in the last two years?
Does Y-mAbs Therapeutics Inc disclose incidents of discrimination?
Does Y-mAbs Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has Y-mAbs Therapeutics Inc issued a profit warning in the past 24 months?
Does Y-mAbs Therapeutics Inc disclose parental leave metrics?
Does Y-mAbs Therapeutics Inc disclose climate scenario or pathway analysis?
Does Y-mAbs Therapeutics Inc disclose current and / or historical scope 1 emissions?
Does Y-mAbs Therapeutics Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Y-mAbs Therapeutics Inc disclose the pay ratio of women to men?
Does Y-mAbs Therapeutics Inc support suppliers with sustainability related research and development?
Does Y-mAbs Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Y-mAbs Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Y-mAbs Therapeutics Inc involved in embryonic stem cell research?
Does Y-mAbs Therapeutics Inc disclose GHG and Air Emissions intensity?
Does Y-mAbs Therapeutics Inc disclose its waste policy?
Does Y-mAbs Therapeutics Inc report according to TCFD requirements?
Does Y-mAbs Therapeutics Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Y-mAbs Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Y-mAbs Therapeutics Inc disclose energy use targets?
Does Y-mAbs Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Y-mAbs Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Y-mAbs Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.